Skip to content

Evommune EVMN Shares (Basic)

Shares (Basic) at other companies

Pfizer logo
PfizerPFE
5.7B+0.3%
Bausch + Lomb logo
Bausch + LombBLCO
355.2M+0.7%
BillionToOne, Inc.
 logo
BillionToOne, Inc. BLLN
45.9M+345%
Perrigo Company logo
Perrigo CompanyPRGO
138.7M+0.7%
Hims & Hers Health logo
Hims & Hers HealthHIMS
228.4M+2.9%

Other financials

Income statement

See full
Revenue$1.6M+3.5%
Gross profit$961.1K+10.9%
Operating income-$682.8K-2,027%
Net income-$7.0M-5,414%
EPS (diluted)-$0.36-1,700%

Balance sheet

See full
Cash & equivalents$1.1M+401%
Total debt$2.0M
Total equity-$4.5M-3,048%
Total assets$7.2M

Cash flow

See full
Operating cash flow-$424.6K-341%
CapEx$1.0-99.8%
Free cash flow-$2.7M-4,996%

Valuation

See full
Market cap$848.59M+39.5%
Enterprise value$849.52M
P/S127.3×

Profitability

See full
Gross margin53.7%
Operating margin-30.7%
Net margin-90.1%

Returns & leverage

See full
Return on equity275.7%
Debt / equity1.4×
Current ratio1.2×

Where this comes from

Reported directly by Evommune in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfSharesOutstandingBasic.

The official record: Evommune ’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Evommune 's shares (basic).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Evommune 's shares (basic)?
Evommune (EVMN) reported shares (basic) of 19.6M in Q1 2026.
How has Evommune 's shares (basic) changed year-over-year?
Evommune 's shares (basic) increased by 183.3% year-over-year, from 6.9M to 19.6M.
What does shares (basic) mean?
The time-weighted average number of common shares outstanding during the period, used as the denominator for basic EPS calculations.